Daniel R Kuritzkes, MD
Brigham and Women's Hospital Therapeutics CRS, Harvard Medical School · Massachusetts General Hospital · Brigham and Women's Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Daniel R Kuritzkes, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:59 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT03705169 · Pharmacokinetics and Safety of SAR441236National Institute of Allergy and Infectious Diseases (NIAID) · terminated · HIV-1-infection · study chair
- Ph1/Ph2NCT02471430 · Reducing the Residual Reservoir of HIV-1 Infected Cells in Patients Receiving Antiretroviral TherapyMassachusetts General Hospital · completed · HIV Infection · principal investigator
- Ph2/Ph3NCT02369406 · Early Infant HIV Treatment in BotswanaHarvard School of Public Health (HSPH) · active not recruiting · HIV, Pediatric AIDS · principal investigator
- N/ANCT00709397 · HIV-1 Viral Dynamics in Subjects Initiating Raltegravir TherapyBrigham and Women's Hospital · terminated · HIV-1 Infection · principal investigator
- Ph1/Ph2NCT00031044 · Adding New Drugs for HIV Infected Patients Failing Current TherapyNational Institute of Allergy and Infectious Diseases (NIAID) · completed · HIV Infections · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:59 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.